KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Arbutus Biopharma (ABUS) over the last 16 years, with Q3 2025 value amounting to 0.15.

  • Arbutus Biopharma's Asset Utilization Ratio rose 22390.49% to 0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15, marking a year-over-year increase of 22390.49%. This contributed to the annual value of 0.04 for FY2024, which is 5813.37% down from last year.
  • Arbutus Biopharma's Asset Utilization Ratio amounted to 0.15 in Q3 2025, which was up 22390.49% from 0.14 recorded in Q2 2025.
  • Arbutus Biopharma's 5-year Asset Utilization Ratio high stood at 0.2 for Q4 2022, and its period low was 0.04 during Q3 2024.
  • Over the past 5 years, Arbutus Biopharma's median Asset Utilization Ratio value was 0.1 (recorded in 2022), while the average stood at 0.1.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 22918.65% in 2022, then crashed by 6615.78% in 2024.
  • Quarter analysis of 5 years shows Arbutus Biopharma's Asset Utilization Ratio stood at 0.06 in 2021, then skyrocketed by 229.19% to 0.2 in 2022, then plummeted by 38.75% to 0.12 in 2023, then tumbled by 62.12% to 0.05 in 2024, then surged by 220.5% to 0.15 in 2025.
  • Its Asset Utilization Ratio was 0.15 in Q3 2025, compared to 0.14 in Q2 2025 and 0.05 in Q1 2025.